Study identifies risk for some childhood cancer patients developing secondary leukemia

Open, expressive family life may reduce social deprivation effects among adopted children
28 May 2021
How the production of antibodies is regulated, one cell at a time
28 May 2021

Study identifies risk for some childhood cancer patients developing secondary leukemia

Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma—a cancer of immature nerve cells—treatment with platinum chemotherapy caused changes to the genome that could then cause leukemia in some children later on.

Comments are closed.